Targeting the anti-inflammatory interplay promoting glioblastoma progression with combined natural killer cells and mab9.2.27 against NG2/CSPG4. A novel strategy to reveal glioblastoma to the immune system

@inproceedings{Poli2013TargetingTA,
  title={Targeting the anti-inflammatory interplay promoting glioblastoma progression with combined natural killer cells and mab9.2.27 against NG2/CSPG4. A novel strategy to reveal glioblastoma to the immune system},
  author={Aur{\'e}lie Poli},
  year={2013}
}
............................................................................................................................................... 11 1. LIST OF ARTICLES ....................................................................................................................... 13 2. INTRODUCTION ............................................................................................................................. 14 2.1. Classification, incidence and prognosis of GBM… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 602 REFERENCES

AIM-2: a novel tumor antigen is expressed and presented by human glioma cells.

  • Journal of immunotherapy
  • 2004
VIEW 17 EXCERPTS
HIGHLY INFLUENTIAL

Cellular-Based Immunotherapies for Patients with Glioblastoma Multiforme

  • Clinical & developmental immunology
  • 2012
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Vaage, A novel NKR-P1B(bright) NK cell subset expresses an activated CD25(+)CX(3)CR1(+)CD62L(-)CD11b(-)CD27(-) phenotype and is prevalent in blood, liver, and gut-associated lymphoid organs of rats

M. Inngjerdingen, L. Kveberg, J.T
  • J Immunol,
  • 2012
VIEW 10 EXCERPTS
HIGHLY INFLUENTIAL

Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study

Salazar, A.M
  • Neurosurgery,
  • 1996
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

IDH1 and IDH2 mutations in gliomas.

  • Current neurology and neuroscience reports
  • 2013
VIEW 15 EXCERPTS
HIGHLY INFLUENTIAL

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma

S Phuphanich
  • Cancer Immunol Immunother,
  • 2013
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2012
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…